Press Release Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBlocĀ® 18 hours ago
Press Release Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update Aug 17
Press Release Femasys Strengthens and Extends Global Patent Protection for FemBlocĀ® with First Issued Blended Polymer Patents Aug 12